Product
SHR6508
3 clinical trials
2 indications
Indication
Secondary HyperparathyroidismClinical trial
Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical TrialStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
An Open-label, Randomized, Active-Controlled Dose Titration Study to Assess the Efficacy and Safety of SHR6508 in Hemodialysis Subjects With Secondary HyperparathyroidismStatus: Active (not recruiting), Estimated PCD: 2023-10-31
Clinical trial
A Multicenter, Randomised, Double-blind, Double-dummy Study to Assess the Efficacy and Safety of SHR6508 in Hemodialysis Subjects With Secondary HyperparathyroidismStatus: Not yet recruiting, Estimated PCD: 2025-06-01